317 related articles for article (PubMed ID: 24764660)
1. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
Takeda A; Sanuki N; Kunieda E
World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
[TBL] [Abstract][Full Text] [Related]
2. [Role of stereotactic radiotherapy in the treatment of oligometastatic colorectal cancer].
Pouypoudat C; Trouette R; Bernard B; Vendrely V
Cancer Radiother; 2021 Oct; 25(6-7):523-525. PubMed ID: 34454836
[TBL] [Abstract][Full Text] [Related]
3. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.
Seo YS; Kim MS; Yoo HJ; Jang WI
World J Gastroenterol; 2014 Feb; 20(8):2005-13. PubMed ID: 24587675
[TBL] [Abstract][Full Text] [Related]
5. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
[TBL] [Abstract][Full Text] [Related]
6. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
7. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for oligometastases.
Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.
Jingu K; Matsushita H; Yamamoto T; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Kadoya N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794936. PubMed ID: 30145943
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
Thompson R; Cheung P; Chu W; Myrehaug S; Poon I; Sahgal A; Soliman H; Tseng CL; Wong S; Ung Y; Beatriz Kinupe Abrahão A; Erler D; Zhang L; Ko YJ; Chung HT
Radiother Oncol; 2020 Jan; 142():236-245. PubMed ID: 31543287
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience.
Alsuhaibani A; Elashwah A; Alkafi A; Constantinescus C; ALzorkany F
J Gastrointest Cancer; 2019 Dec; 50(4):879-887. PubMed ID: 30291546
[TBL] [Abstract][Full Text] [Related]
12. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
[TBL] [Abstract][Full Text] [Related]
13. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
Klement RJ; Abbasi-Senger N; Adebahr S; Alheid H; Allgaeuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Eble MJ; Ernst I; Gerum S; Habermehl D; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lewitzki V; Lohaus F; Ostheimer C; Papachristofilou A; Petersen C; Rieber J; Schneider T; Schrade E; Semrau R; Wachter S; Wittig A; Guckenberger M; Andratschke N
BMC Cancer; 2019 Feb; 19(1):173. PubMed ID: 30808323
[TBL] [Abstract][Full Text] [Related]
14. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer.
Jingu K; Matsuo Y; Onishi H; Yamamoto T; Aoki M; Murakami Y; Yamashita H; Kakuhara H; Nemoto K; Sakayauchi T; Okamoto M; Niibe Y; Nagata Y; Ogawa K
Anticancer Res; 2017 May; 37(5):2709-2713. PubMed ID: 28476849
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy for Pulmonary Oligometastasis from Colorectal Cancer.
Kobayashi N; Abe T; Noda SE; Kumazaki YU; Hirai R; Igari M; Aoshika T; Saito S; Ryuno Y; Kato S
In Vivo; 2020; 34(5):2991-2996. PubMed ID: 32871842
[TBL] [Abstract][Full Text] [Related]
17. Review and uses of stereotactic body radiation therapy for oligometastases.
Alongi F; Arcangeli S; Filippi AR; Ricardi U; Scorsetti M
Oncologist; 2012; 17(8):1100-7. PubMed ID: 22723509
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E
Christ SM; Alongi F; Ricardi U; Scorsetti M; Livi L; Balermpas P; Lievens Y; Braam P; Jereczek-Fossa BA; Stellamans K; Ratosa I; Widder J; Peulen H; Dirix P; Bral S; Ramella S; Hemmatazad H; Khanfir K; Geets X; Jeene P; Zilli T; Fournier B; Ivaldi GB; Clementel E; Fortpied C; Oppong FB; Ost P; Guckenberger M
Radiother Oncol; 2024 Jun; 195():110235. PubMed ID: 38508239
[TBL] [Abstract][Full Text] [Related]
19. [Local ablative radiotherapy of oligometastatic colorectal cancer].
Petersen C; Gauer T
Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.
Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J
BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
